Outcomes in the EXAMINATION trial

Affiliations

¹ University of Oxford, Oxford OX3 9DU, UK.
² Centre for Evidence-Based Medicine, Oxford, UK. Electronic address: ben.goldacre@phc.ox.ac.uk.

Comment

Henry Drysdale et al. Lancet. 2016.

. 2016 May 14;387(10032):1997-8.

doi: 10.1016/S0140-6736(16)30464-0.

¹ University of Oxford, Oxford OX3 9DU, UK.
² Centre for Evidence-Based Medicine, Oxford, UK. Electronic address: ben.goldacre@phc.ox.ac.uk.

No abstract available

Comment in

Outcomes in the EXAMINATION trial - Authors' reply.
Sabaté M, Brugaletta S; EXAMINATION trial investigators. Sabaté M, et al. Lancet. 2016 May 14;387(10032):1998. doi: 10.1016/S0140-6736(16)30071-X. Lancet. 2016. PMID: 27203777 No abstract available.

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.
Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, van Es GA, Backx B, Valgimigli M, Serruys PW. Sabaté M, et al. Lancet. 2016 Jan 23;387(10016):357-366. doi: 10.1016/S0140-6736(15)00548-6. Epub 2015 Oct 29. Lancet. 2016. PMID: 26520230 Clinical Trial.